SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-23-161659
Filing Date
2023-06-06
Accepted
2023-06-06 16:31:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 DEFM14A d480137ddefm14a.htm DEFM14A 5109376
2 GRAPHIC g443400dsp011.jpg GRAPHIC 176845
3 GRAPHIC g443400g00p19.jpg GRAPHIC 616347
4 GRAPHIC g443400g11t01.jpg GRAPHIC 20707
5 GRAPHIC g443400g11t02.jpg GRAPHIC 28020
6 GRAPHIC g443400g12k55.jpg GRAPHIC 29507
7 GRAPHIC g443400g58q72.jpg GRAPHIC 154913
8 GRAPHIC g443400g84m55.jpg GRAPHIC 47616
9 GRAPHIC g480137dsp010.jpg GRAPHIC 144555
  Complete submission text file 0001193125-23-161659.txt   6765254
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 000-31141 | Film No.: 23996522
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences